tiprankstipranks
Trending News
More News >
Keros Therapeutics (KROS)
NASDAQ:KROS
US Market

Keros Therapeutics (KROS) Balance Sheet

Compare
358 Followers

Keros Therapeutics Balance Sheet

Keros Therapeutics's total assets for Q3 2025 were $742.78M, a decrease of -1.90% from the previous quarter. KROS total liabilities were $39.20M for the fiscal quarter, a -22.26% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Assets
$ 615.89M$ 370.02M$ 306.78M$ 255.25M$ 269.44M
Total Liabilities
$ 44.33M$ 37.81M$ 29.36M$ 12.08M$ 7.72M
Total Equity Gross Minority
$ 571.55M$ 332.21M$ 277.42M$ 243.17M$ 261.72M
Other Metrics
Currency in USD

Keros Therapeutics Debt to Assets